Our engineering efforts focused on applying the design-build-test-learn cycle to create and improve our biosensor system. We aimed to design, test, and refine each step thoughtfully while learning from challenges along the way.
We began by identifying the challenge of developing acne treatments that could prevent inflammation before it occurs. Our goal was to engineer a biosensor system that detects inflammatory biomarkers and produces an anti-inflammatory output.
Based on literature review and mentor guidance, we designed a dual-plasmid AND gate system consisting of:
GFP as a fluorescent reporter temporarily replacing the therapeutic iaaM/iaaH genes (for IAA synthesis) for system validation.
The Hill's Equation for predicting promoter dose-response levels and validating system sensitivity.
These tools helped us visualize circuit logic, select compatible plasmids (pUC19/pSB1C3 and pJUMP-1A), and determine the optimal concentration range of nitric oxide donor and hydrogen peroxide for future characterization.
After finalizing the design, we synthesized custom inserts through Twist Bioscience containing EcoRI and PstI restriction sites.
We began by amplifying the gene inserts via PCR. The PCR conditions were carefully chosen based on the length of the inserts and primer design, with initial annealing temperatures set according to Tm calculations. Once amplified, the inserts were purified and analyzed using gel electrophoresis to confirm the size and yield.
| Component | Volume |
|---|---|
| 2X Buffer | 50 μL |
| Molecular grade H₂O | 32 μL |
| Forward Primers | 1.5 μL |
| Reverse Primers | 1.5 μL |
In parallel, plasmids from the iGEM distribution kit were purified using miniprep protocols. The Kanamycin-resistant plasmid (pJUMP-1A) grew successfully in the TOP10 cells, while the Chloramphenicol-resistant plasmid did not yield colonies, indicating either transformation failure or issues with plasmid concentration. Instead, we chose the pUC19 vector, which was already available in our lab, and contained the correct restriction sites and a compatible ORI site with pJUMP-1A.
Inoculated a liquid culture with the Kan resistant vector.
The next step was the restriction digestion of pUC19 and pJUMP-1A backbones with EcoRI and PstI. Insert DNA was also digested with the same enzymes to generate compatible sticky ends for ligation. Ligation reactions were performed with around 1:2.5 vector:insert molar ratio, which follows the recommendations for complex constructs.
| DNA (PnorV, PoxyS, pJUMP-1A) | DNA (pUC19) | ||
|---|---|---|---|
| Component | Volume | Component | Volume |
| DNA | 12 μL | DNA | 3 μL |
| 10x Buffer | 3 μL | 10x Buffer | 3 μL |
| EcoR1 restriction enzyme | 1 μL | EcoR1 restriction enzyme | 1 μL |
| Pst1 Restriction enzyme | 1 μL | Pst1 Restriction enzyme | 1 μL |
| Molecular H₂O | 13 μL | Molecular H₂O | 22 μL |
| Total | 30 μL | Total | 30 μL |
Plasmid sizes:
PoxyS + Kan vector Ligation:
| 10X T4 Ligase Buffer | 2 μL |
| Kan vector | 3 μL |
| PoxyS | 8 μL |
| Ligase | 1 μL |
| Nuclease-free water | 6 μL |
pUC19 + PnorV Ligation:
| 10X T4 Ligase Buffer | 2 μL |
| pUC19 | 2.5 μL |
| PnorV | 5.5 μL |
| Ligase | 1 μL |
| Nuclease-free water | 9 μL |
Combine and incubate overnight at 16 degrees Celsius in thermocycler
Initial transformations of ligation products into TOP10 cells failed to produce colonies. To improve efficiency, we allowed the bacteria to incubate on ice for 30 minutes before the heat shock and let the transformed cells recover in SOC media for one hour before plating on selective media. This adjustment resulted in successful colonies, which we picked 10 of each plasmid type to grow in LB overnight to increase plasmid yield. Minipreps were performed to isolate the plasmids, which then went through PCR with the insert primers. This step was performed so that if the insert had been successfully ligated into the plasmid, the primers would anneal to the flanking regions and amplify the insert. Gel electrophoresis of these PCR products confirmed the presence or absence of bands corresponding to the expected insert size.
We selected plasmids from colonies 5 and 7 from the pUC19-PnorV plasmids and plasmids from colonies 1 and 7 from the pJUMP-PoxyS plasmids.
To validate the assembly, we:
Sequencing results revealed that most plasmids were empty backbones without inserts. One Kanamycin vector showed recombination with E. coli genomic DNA, resulting in unintended GFP expression. This indicated that while some ligations had occurred, the majority of colonies did not carry the intended constructs.
pUC19-PnorV refers to the plasmid containing the insert responsible for detecting nitric oxide and producing LuxR
pJUMP-PoxyS refers to the plasmid containing the insert responsible for detecting hydrogen peroxide and producing AHL, and then finally GFP
pUC19-PnorV from colony 5
pUC19-PnorV from colony 7
pJUMP-PoxyS from Colony 1
pJUMP-PoxyS from Colony 7
These outcomes may be due to digestion failure and low insert:vector ratios despite continued PCR.
From our troubleshooting and results, we gained several key insights:
Based on the lessons learned from our first iteration, we optimized our approach for the second build cycle.
In Build 2, we implemented lessons from the first round to improve our workflow. We performed an optimized PCR to maximize insert concentration, extending elongation times and adjusting cycle numbers. PCR cleanup was used instead of gel extraction to prevent DNA loss through the extraction process.
Restriction digests were repeated and incubated overnight to ensure complete digestion. Gel electrophoresis was used to confirm the digest success.
Digestion of pUC19 and pJUMP worked. For pUC19, the restriction enzymes weren't cutting out a section of the plasmid, which is why the digested and undigested are similar in length. However, the undigested is still slightly further down because it is in circular form while the digested is linearized. Linear will move slightly slower in the gel than the circular DNA. For the pJUMP vector, the undigested form is heavier and intact while the digested moved farther down, which means it has been successfully digested by the restriction enzymes.
Loading order (R → L): ladder, undigested pUC19, digested pUC19, undigested pJUMP, digested pJUMP, digested PnorV, digested PoxyS.
Insert bands were faint which may be due to low PCR yield, so we reused digested inserts from Build 1 for ligation. Ligation reactions were performed using the optimized 3:1 insert:vector ratios. We cut out the bands for the digested vectors and performed gel extraction to only use the digested vectors. We then transformed the ligated product.
Transformed products were plated on selective media. TOP10 cells were used as NEB Stable competent cells had not yet arrived. Unfortunately, no colonies were obtained, and only the negative control showed bacterial growth. This suggested possible errors in PCR amplification during the elongation cycles, resulting in insufficient concentration of insert DNA despite using a maximally optimized protocol, which may have affected the ligation reaction.
Ligation set up (aiming for 3:1 or 4:1 ratio). Used 2μL 10× Ligase Buffer and 1μL Ligase per reaction. Total volume 20μL.
Ligation mixes incubated at RT for 2 hours.
Transformation into Top10 E. coli cells from −80°C. Positive and negative controls included.
Protocol:
These steps provided extensive hands-on experience with PCR optimization, plasmid miniprep, gel extraction, restriction digestion, NanoDrop spectrophotometry, ligation, transformation, miniprep, troubleshooting, and insert confirmation.
For our next engineering cycle, we plan to: